Circulating concentrations of GLP-1 cause the beta-cells in the pancreas to release insulin, which lowers blood glucose, and activity in various regions of the central nervous system reduces appetite and enhances satiety
Large clinical trials have shown: Approximately 20% reduction in major CV events Reduced proteinuria and slower kidney function decline Improved quality of life and energy levels Additional Systemic Effects Research also suggests benefits across other domains: Sleep quality: Weight lossdriven reductions in apnea severity Neurocognitive health: Early signals of protection against dementia, though definitive evidence is still developing Together, these outcomes position GLP-1s as a unifying therapy for overlapping metabolic, cardiovascular and renal conditions
Top 10 Ozempic Benefits: Everything You Need to Know Ozempic offers a range of benefits, including weight loss support, improved blood sugar control, and reduced heart disease risk
Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: A 52-week, open-label, phase IV study
Their new business model often focuses on a different value now, helping patients navigate insurance prior authorizations for the real-deal GLP-1s
